New cucurbitane triterpenoids with cytotoxic activities from Hemsleya penxianensis
- 1 July 2017
- journal article
- Published by Elsevier in Fitoterapia
- Vol. 120, 158-163
Abstract
No abstract availableKeywords
Funding Information
- Technological Large Platform (2012ZX09301-002-001-026)
- National Natural Sciences Foundation of China (81502945)
- PUMC Youth Fund (3332015141)
- CAMS Innovation Fund for Medical Science (CIFMS) (2016-I2M-1-012)
This publication has 17 references indexed in Scilit:
- Three new cucurbitane triterpenoids from Hemsleya penxianensis and their cytotoxic activitiesBioorganic & Medicinal Chemistry Letters, 2014
- Cucurbitacin IIa induces caspase-3-dependent apoptosis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophagesInternational Immunopharmacology, 2013
- Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylationBritish Journal of Cancer, 2011
- Anti-HIV-1 Activities of Hemslecins A and BChinese Journal of Natural Medicines, 2008
- Investigation of antimicrobial model of Hemsleya pengxianensis W.J. Chang and its main active component by metabolomics techniqueJournal of Ethnopharmacology, 2007
- Four New Cucurbitane Glycosides fromHemsleya jinfushanensisPlanta Medica, 2005
- Cucurbitacins and cucurbitane glycosides: structures and biological activitiesNatural Product Reports, 2005
- Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activityOncogene, 2005
- Anticancer activity of Hemsleya amabilis extractLife Sciences, 2002
- Cucurbitacins and their pharmacological effectsPhytotherapy Research, 1995